Intended Use

BrainInsight is intended for automatic labeling, spatial measurement, and volumetric quantification of brain structures from a set of low-field MR images and returns annotated and segmented images, color overlays and reports.

Technology

BrainInsight uses a proprietary automated internal pipeline based on machine learning to process low-field MR images, performing segmentation, volume calculation, distance measurement, and generating color overlays and reports. It operates as cloud-based software compatible with FDA-cleared PACS and supports DICOM image input and output.

Performance

Performance testing included software verification per IEC 62304:2006, training on multi-site annotated datasets of low-field MRI scans including stroke, hemorrhage, and tumor pathology. Validation showed high agreement with expert annotations (Dice coefficients around 80-95%) and accurate midline shift measurements (mean error ~1 mm), meeting all acceptance criteria for substantial equivalence.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    3/21/2022

    4 months
  • 2

    FDA Approval

    7/19/2022

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.